Item 8.01 Other Events.
Effective Form S-1 Registration Statement and DTC Eligibility
On September 2, 2021, Vitality Biopharma, Inc. (the "Company") issued a press
release announcing 1) that the Securities and Exchange Commission has declared
as effective the Company's Form S-1 registration statement, as amended, that was
filed on August 31, 2021, and 2) that the Depository Trust Company ("DTC")
deemed the Company's common shares eligible for electronic clearing and
settlement through the DTC.
The foregoing description of the press release does not purport to be complete
and is qualified in its entirety by reference to the full text of the document.
A copy of the press release is attached to this Current Report on Form 8-K as
Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
Exhibit No. Description
99.1 Press Release, dated September 2, 2021
104 Cover Page Interactive Data File (embedded within the Inline XBRL
© Edgar Online, source Glimpses